Myeloproliferative Disorders
"Myeloproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
Descriptor ID |
D009196
|
MeSH Number(s) |
C15.378.190.636
|
Concept/Terms |
Myeloproliferative Disorders- Myeloproliferative Disorders
- Disorder, Myeloproliferative
- Disorders, Myeloproliferative
- Myeloproliferative Disorder
|
Below are MeSH descriptors whose meaning is more general than "Myeloproliferative Disorders".
Below are MeSH descriptors whose meaning is more specific than "Myeloproliferative Disorders".
This graph shows the total number of publications written about "Myeloproliferative Disorders" by people in this website by year, and whether "Myeloproliferative Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 3 | 1 | 4 |
2004 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 4 | 1 | 5 |
2009 | 5 | 0 | 5 |
2010 | 2 | 0 | 2 |
2011 | 3 | 0 | 3 |
2012 | 1 | 0 | 1 |
2013 | 2 | 0 | 2 |
2014 | 3 | 0 | 3 |
2015 | 2 | 0 | 2 |
2016 | 3 | 1 | 4 |
2017 | 2 | 1 | 3 |
2018 | 2 | 0 | 2 |
2019 | 2 | 0 | 2 |
2020 | 4 | 0 | 4 |
2021 | 1 | 1 | 2 |
2022 | 14 | 0 | 14 |
2023 | 13 | 0 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myeloproliferative Disorders" by people in Profiles.
-
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. Mod Pathol. 2024 Jan; 37(1):100352.
-
Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach. Am J Clin Pathol. 2023 10 03; 160(4):365-393.
-
Germ line risk variants: beyond cancer. Blood. 2023 08 17; 142(7):616-617.
-
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes. Leuk Lymphoma. 2023 09; 64(9):1562-1565.
-
The international consensus classification of eosinophilic disorders and systemic mastocytosis. Am J Hematol. 2023 08; 98(8):1286-1306.
-
The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition. Am Soc Clin Oncol Educ Book. 2023 Jun; 43:e390026.
-
Small but mighty: T-replete cords for myeloid disease. Blood Adv. 2023 05 23; 7(10):2153-2154.
-
DDX41-associated susceptibility to myeloid neoplasms. Blood. 2023 03 30; 141(13):1544-1552.
-
Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation. Leuk Res. 2023 04; 127:107033.
-
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood. 2023 02 02; 141(5):534-549.